← Back to patent-cliff list
TOL-463
Tier C — Watch / tradeTOL-463
Niaid
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：Not applicable
Indications (approved)：细菌性阴道病, Vulvovaginal candidiasis, Vaginal disease
Regional status
US
Phase II
2016-07-15
EU
-
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of TOL-463?
Approved indications include: 细菌性阴道病, Vulvovaginal candidiasis, Vaginal disease.
When does the TOL-463 patent expire?
No public expiry year is available for TOL-463 yet; this page updates once verified.
How do I get a quote for TOL-463 intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-10